Capricor Therapeutics and Parents Project Muscular Dystrophy to Host Webinar to Discuss Interim Analysis of the HOPE-2 Clinical Trial to Treat Patients with Duchenne Muscular Dystrophy

Stock Information for Capricor Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.